- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/088 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Patent holdings for IPC class C07D 295/088
Total number of patents in this class: 462
10-year publication summary
|
35
|
32
|
26
|
37
|
41
|
32
|
28
|
30
|
31
|
22
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Alkermes Pharma Ireland Limited | 254 |
14 |
| Corsair Pharma, Inc. | 37 |
14 |
| FUJIFILM Corporation | 30516 |
13 |
| Dow Global Technologies LLC | 10960 |
9 |
| The University of British Columbia | 1546 |
9 |
| Novartis AG | 10251 |
8 |
| British Columbia Cancer Agency Branch | 182 |
7 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3003 |
7 |
| Translate bio, Inc. | 415 |
7 |
| BASF SE | 21308 |
6 |
| The Scripps Research Institute | 1340 |
6 |
| Wave Life Sciences Ltd. | 222 |
6 |
| Gotion Inc. | 39 |
6 |
| Sumitomo Chemical Company, Limited | 8968 |
5 |
| Board of Regents, The University of Texas System | 6117 |
5 |
| Emory University | 1723 |
5 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
5 |
| Xiamen Sinopeg Biotech Co., Ltd. | 68 |
5 |
| Sanofi | 4307 |
5 |
| Merck Patent GmbH | 5729 |
4 |
| Other owners | 316 |